A study on clinical profile of neurological manifestations among HIV infected patients attending a tertiary care hospital of south India

Authors

  • Chandra Sekara Reddy Munamala Department of General Medicine, Narayana Medical College, Andhra Pradesh, India
  • Ramesh Babu Pannem Department of General Medicine, Narayana Medical College, Andhra Pradesh, India

DOI:

https://doi.org/10.18203/2349-3933.ijam20184685

Keywords:

AIDS, CD4 count, Cryptococcal meningitis, HIV, Tubercular meningitis

Abstract

Background: Current statistics show that 36.9 million (31.1-43.9 million) people were living with HIV globally at the end of 2017. 15-73% of people with HIV may develop neurological disorders with sometimes as a presenting illness. The aim of present study is to document the various neurological manifestations and presentations with relation to CD4 counts among the HIV/AIDS cases attending a tertiary care hospital of south India.

Methods: A prospective study was conducted for two years at a tertiary care hospital among confirmed cases of HIV and the neurological manifestations were diagnosed and clinical signs and symptoms were noted. CD4 counts of all the cases were performed by FACS counter and Neuroimaging study was performed on necessary cases.

Results: Total of 125 cases with 69.6% males and 30.4% females were enrolled. Mean age of cases was 35.14±3.8years. 86.4% were positive for HIV-1 type. Headache was the most common ailment (78.4%). Meningeal enhancement observed in 24.5% followed in order by ring enhancing lesion (18.37%), cerebral atrophy and infarction (12.24%). Tubercular meningitis was the commonest type (33.6%). In 12 cases of cryptococcal meningitis the CD4 counts were <100 cells/mm3.

Conclusions: To conclude in present study, secondary neurological manifestations were more common than primary manifestations in present study. Tubercular meningitis being the most common and CD4 counts <100cells/mm3 were associated with cryptococcal meningitis. Cases with CD4 counts less than 100cells/mm3 had poor prognosis.

References

UNAIDS. Press release: 2.5 million people in India living with HIV, according to new estimates. 2007 Jul 6th. Available at: http://data.unaids.org/pub/pressrelease/2007/070706_indiapressrelease_en.pdf.

Revised Surveillance Case Definition for HIV Infection - United States, 2014. Available at: www.cdc.govmmwr/preview/mmwrhtml/rr6303a1.htm?s_cid=rr6303a1_e.

Deshpande AK, Patnaik MM. Nonopportunistic neurologic manifestations of the human immunodeficiency virus: an Indian study. J Int AIDS Society. 2005 Dec;7(4):2.

Mwanza JC, Nyamabo LK, Tylleskär T, Plant GT. Neuro-ophthalmological disorders in HIV infected subjects with neurological manifestations. Br J Ophthalmol. 2004 Nov 1;88(11):1455-9.

Fauci AS, Lane HC. Human immunodeficiency virus disease: AIDS and related disorders. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al. editors. Harrison's Principle of Internal Medicine. 17th ed. New York: McGraw-Hill; 2008:1137-204.

Wadia RS, Pujari SN, Kothari S, Udhar M, Kulkarni S, Bhagat S, et al. Neurological manifestations of HIV disease. J Association Physicians India. 2001 Mar;49:343-8.

Millogo A, Ki-Zerbo GA, Sawadogo AB, Ouedraogo I, Yameogo A, et al. Neurologic manifestations associated with HIV infections at the Bobo-Dioulasso Hospital Center (Burkina Faso). 1999 Feb;92(1):23-6.

John TJ, Babu PG, Saraswathi NK, Jayakumari H, Selvaraj R, Kaur A, et al. The epidemiology of AIDS in the Vellore region, southern India. AIDS (London, England). 1993 Mar;7(3):421-4.

Bollinger RC, Tripathy SP, Quinn TC. The human immunodeficiency virus epidemic in India. Current magnitude and future projections. Medicine. 1995 Mar;74(2):97-106.

Pal J, Karmakar PS, Ray A, Saha S, Roy K, Talukdar A, et al. Opportunistic infections of central nervous system in AIDS. J Indian Med Assoc. 2009;107:446-9.

Berger JR, Stein N, Pall L. Headache and human immunodeficiency virus infection: a case control study. Eur Neurol. 1996;36:229-33.

Skolasky RL, Dal Pan GJ, Olivi A, Lenz FA, Abrams RA, McArthur JC. HIV-associated primary CNS lymorbidity and utility of brain biopsy. J Neurological Sci. 1999 Feb 1;163(1):32-8.

Sircar AR, Tripathi AK, Choudhary SK, Misra R. Clinical profile of AIDS: a study at a referral hospital. J Association Physicians India. 1998 Sep;46(9):775-8.

Antinori A, Ammassari A, De Luca A, Cingolani A, Murri R, Scoppettuolo G, et al. Diagnosis of AIDS-related focal brain lesions A decision-making analysis based on clinical and neuroradiologic characteristics combined with polymerase chain reaction assays in CSF. Neurology. 1997 Mar 1;48(3):687-94.

Kwan CK, Ernst JD. HIV and tuberculosis: a deadly human syndemic. Clin Microbiol Revi. 2011 Apr 1;24(2):351-76.

Cohen DB, Zijlstra EE, Mukaka M, Reiss M, Kamphambale S, Scholing M, et al. Diagnosis of cryptococcal and tuberculous meningitis in a resource‐limited African setting. Tropical Med Int Health. 2010 Aug;15(8):910-7.

Rana HM, Doshi DA, Virpariya KM, Shah AN, Somani SS. A study of clinical profile of HIV positive patients with neurological manifestations. HIV AIDS Review. 2011;171-4.

Maschke M, Kastrup O, Esser S, Ross B, Hengge U, Hufnagel A. Incidence and prevalence of neurological disorders associated with HIV since the introduction of highly active antiretroviral therapy (HAART). J Neurol Neurosurg Psychiatry. 2000 Sep 1;69(3):376-80.

Mansuri ZH, Kazi BC. Changadiya KHl. A study of clinical profile of neurological manifestations in HIV positive patients with reference to CD4 Cell Count. Int J Scientific Res. 2014;3(10):329-1.

Downloads

Published

2018-11-22

Issue

Section

Original Research Articles